383 results on '"Yoh, Tomoaki"'
Search Results
52. Further to the Right: Piggyback Anastomosis on the Right Hepatic Vein Facilitates the Implantation of Small Liver Grafts (the One-vein Technique)
53. Modified technique of total hepatectomy in polycystic liver disease with caval flow preservation: the exposure left lateral sectionectomy
54. Nonsuperiority of technetium-99m-galactosyl human serum albumin scintigraphy over conventional volumetry for assessing the future liver remnant in patients undergoing hepatectomy after portal vein embolization
55. Ferroptosis-related gene glutathione peroxidase 4 promotes reprogramming of glucose metabolism via Akt–mTOR axis in intrahepatic cholangiocarcinoma.
56. Trends in long‐term outcomes of patients with HCV‐associated hepatocellular carcinoma after hepatectomy: A comparison before and after introduction of direct‐acting antivirus therapy.
57. Transfissural Approach for Laparoscopic Resection of a Deep Segment 8 Lesion in Contact with the Hepatocaval Confluence
58. Proposal of a New Preoperative Prognostic Model for Solitary Hepatocellular Carcinoma Incorporating 18F-FDG-PET Imaging with the ALBI Grade
59. Phase I clinical trial of olprinone in liver surgery
60. Is routine abdominal drainage necessary after liver resection?
61. Hepatic Recurrence of Neuroendocrine Tumor Component in Gallbladder Cancer.
62. ASO Author Reflections: Defining Oligometastatic Recurrence in Biliary Tract Cancer
63. Supplementary Data from Serum Nardilysin, a Surrogate Marker for Epithelial–Mesenchymal Transition, Predicts Prognosis of Intrahepatic Cholangiocarcinoma after Surgical Resection
64. Preoperative metabolic tumor volume of intrahepatic cholangiocarcinoma measured by 18F-FDG-PET is associated with the KRAS mutation status and prognosis
65. Significant Improvement in Outcomes of Patients with Intrahepatic Cholangiocarcinoma after Surgery
66. Cholangiolocellular carcinoma with rapid progression initially showing abnormally elevated serum alfa-fetoprotein
67. Utility of serum autotaxin levels for predicting post hepatectomy liver failure in hepatocellular carcinoma
68. Correction: A Conceptual Classification of Resectability for Hepatocellular Carcinoma
69. A Conceptual Classification of Resectability for Hepatocellular Carcinoma
70. Bile Duct Regeneration with an Artificial Bile Duct Made of Gelatin Hydrogel Nonwoven Fabrics
71. Increased expression of programmed cell death ligand 1 and galectin 9 in transplant recipients who achieved tolerance after immunosuppression withdrawal
72. ASO Author Reflections: Proposal of a New Preoperative Prognostic Model for Solitary Hepatocellular Carcinoma
73. The usefulness of preoperative bile cultures for hepatectomy with biliary reconstruction
74. Dissecting aneurysm of the proper hepatic artery after laparoscopic hepatectomy possibly related to the Pringle maneuver: A case report
75. Bile Duct Regeneration with an Artificial Bile Duct Made of Gelatin Hydrogel Nonwoven Fabrics
76. Modification of the "new world" terminology: A new comprehensive notation for hepatectomy.
77. COVID-19 Incidence and its Clinical Course in Liver Transplant Recipients
78. An International Retrospective Observational Study of Liver Functional Deterioration after Repeat Liver Resection for Patients with Hepatocellular Carcinoma
79. EP1202: QUANTITATIVE ASSESSMENT OF MICROVASCULAR INVASION IN HEPATOCELLULAR CARCINOMA USING PREOPERATIVE DCP AND FDGPET
80. EP1204: TREATMENT OUTCOMES OF RECURRENT HEPATOCELLULAR CARCINOMA AFTER HEPATECTOMY IN THE ERA OF MOLECULAR TARGETED AGENTS.
81. Multicystic biliary hamartoma mimicking intrahepatic cholangiocarcinoma: report of a case
82. Utility of serum autotaxin levels for predicting post hepatectomy liver failure in hepatocellular carcinoma.
83. Dissecting aneurysm of the proper hepatic artery after laparoscopic hepatectomy possibly related to the Pringle maneuver: A case report
84. The Usefulness of Preoperative Bile Cultures for Hepatectomy with Biliary Reconstruction
85. Reappraisal of Prognostic Impact of Tumor SUVmax by F-FDG-PET/CT in Intrahepatic Cholangiocarcinoma
86. Increased Expressions of Programmed Death Ligand 1 and Galectin 9 in Transplant Recipients Who Achieved Tolerance After Immunosuppression Withdrawal
87. The long-term outcomes of laparoscopic versus open pancreatoduodenectomy for ampullary carcinoma showed similar survival: a case-matched comparative study
88. Correction to: Learning process of laparoscopic liver resection and postoperative outcomes: chronological analysis of single-center 15-years’ experience
89. Anatomy of the Middle Hepatic Vein Tributaries to Promote Safer Hepatic Vein-Guided Liver Resection
90. Learning process of laparoscopic liver resection and postoperative outcomes: chronological analysis of single-center 15-years’ experience
91. Limited Impact of HER2 Expression on Survival Outcomes in Patients with Intrahepatic Cholangiocarcinoma After Surgical Resection
92. Multicenter Propensity Score-Based Study of Laparoscopic Repeat Liver Resection for Hepatocellular Carcinoma: A Subgroup Analysis of Cases with Tumors Far from Major Vessels
93. Correction to: Proposed Definition for Oligometastatic Recurrence in Biliary Tract Cancer Based on Results of Locoregional Treatment: A Propensity-Score-Stratified Analysis
94. Transfissural Approach for Laparoscopic Resection of a Deep Segment 8 Lesion in Contact with the Hepatocaval Confluence
95. Sa1571 THE RELATIONSHIP BETWEEN FDG UPTAKE, MARKERS OF SYSTEMIC INFLAMMATORY RESPONSE AND OUTCOME IN INTRAHEPATIC CHOLANGIOCARCINOMA
96. Sa1573 IMPACT OF THE PRINGLE MANEUVER ON LIVER INJURY DURING LAPAROSCOPIC HEPATECTOMY
97. Complete Metabolic Response by 18 F-FDG PET/CT to Atezolizumab Plus Bevacizumab in Patients With Advanced Hepatocellular Carcinoma.
98. Increased Expressions of Programmed Death Ligand 1 and Galectin 9 in Transplant Recipients Who Achieved Tolerance After Immunosuppression Withdrawal.
99. THU167 - Increased expression of programmed cell death ligand 1 and galectin 9 in transplant recipients who achieved tolerance after immunosuppression withdrawal
100. Identifying Patients Who May Benefit from Liver Resection Compared to Living Donor Liver Transplantation for Hepatocellular Carcinoma Using 18F-FDG PET.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.